Skip to content
Winnowleaf home

Do any vitamins help type 1 diabetes?

No vitamin replaces insulin or has been shown to change the course of type 1 diabetes. Vitamin D, the most studied, gave mixed, low-certainty results in a 2025 review of 12 small trials, with no change in HbA1c, the long-term blood sugar measure (grade C). Vitamin B3 did not stop diabetes in 552 people with a high-risk family history, and active vitamin D did not protect insulin-making cells. Any glucose-lowering supplement can change insulin needs.

Last reviewed

How we grade evidenceEditorial policy

What the studies found

  • Grade C. Vitamin D (cholecalciferol) gives mixed, low-certainty results. A 2025 review of 12 trials, focused on children and teens, found no change in HbA1c, slightly lower insulin doses and fasting glucose, and unexpectedly lower C-peptide, a marker of the body's own insulin. One 18-month trial of 38 newly diagnosed patients found fewer lost all C-peptide (18.7% against 62.5%). (Fan 2025; Gabbay 2012)
  • Grade B. Active vitamin D (calcitriol, a prescription form) did not help. In two placebo-controlled trials of newly diagnosed patients, 34 people aged 11 to 35 and 40 adults, insulin-making cell function declined just as fast, with no change in HbA1c or insulin needs. (Bizzarri 2010; Walter 2010)
  • Grade B. Vitamin B3 did not stop type 1 diabetes from starting. In 552 relatives at high risk, nicotinamide for 5 years made no difference: 82 developed diabetes on it against 77 on placebo. (Gale 2004)
  • Grade C. Omega-3 fish oil lowered HbA1c slightly (by 0.33 points) in 4 small trials, but a 2024 review rated it low quality and said no supplement could be recommended for type 1 diabetes. (Ferraz 2024)

Who should be careful

  • Never cut or skip insulin because of a supplement. Get emergency care for vomiting, belly pain, fruity breath, fast breathing or confusion, which can be signs of diabetic ketoacidosis.
  • Berberine, chromium, cinnamon and other glucose-lowering products have no good trials in type 1 diabetes. If you add one, test your glucose more often and let your diabetes team know, because lows are possible. No interaction studies with insulin were found.
  • For adults, the vitamin D upper limit is 4,000 IU a day (NIH ODS). Limits are lower at younger ages; ask for a blood test before taking high doses.
  • If you are pregnant, breastfeeding or under 18, ask a clinician first.

Try first

  • Insulin plus continuous glucose monitoring. Across 21 trials with 2,149 people, continuous monitors lowered HbA1c more than finger-stick checks, especially when HbA1c started above 8%. (Teo 2022)
  • Ask your diabetes team to check vitamin D and other levels if a shortage is suspected, and to treat a confirmed deficiency.

Sources

  1. Fan S, et al. Vitamin D supplementation in individuals with type 1 diabetes mellitus (T1DM): a systematic review and meta-analysis focusing on pediatrics. Diabetol Metab Syndr. 2025. PubMed 41350745 · doi:10.1186/s13098-025-02008-9
  2. Gabbay MA, et al. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med. 2012. PubMed 22751874 · doi:10.1001/archpediatrics.2012.164
  3. Bizzarri C, et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care. 2010. PubMed 20805274 · doi:10.2337/dc10-0814
  4. Walter M, et al. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care. 2010. PubMed 20357369 · doi:10.2337/dc09-2297
  5. Gale EA, et al. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet. 2004. PubMed 15043959 · doi:10.1016/S0140-6736(04)15786-3
  6. Ferraz LC, et al. Effects of dietary supplementation in treatment and control of progression and complications of insulin-dependent diabetes mellitus: a systematic review with meta-analyses of randomized clinical trials. Braz J Med Biol Res. 2024. PubMed 39194033 · doi:10.1590/1414-431X2024e13649
  7. Teo E, et al. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022. PubMed 35141761 · doi:10.1007/s00125-021-05648-4